Geron halts late-stage blood cancer drug trial; shares plunge
Geron halted a late-stage trial of a blood cancer drug, and its shares plunged.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Geron halts late-stage blood cancer drug trial
Geron said it will discontinue a late-stage trial of a treatment for patients with a type of rare blood cancer.